Missed Opportunities in Public Health and Biomedical Research Act of 2020
This bill requires the National Institutes of Health to annually report on certain unfunded applications for research grants that had potential for improving public health.
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7544 Introduced in House (IH)]
<DOC>
116th CONGRESS
2d Session
H. R. 7544
To amend the Public Health Service Act to require reporting by the
National Institutes of Health on requests for funding research that
were not granted and had the greatest potential for improving public
health, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
July 9, 2020
Mr. Lewis (for himself, Ms. Kelly of Illinois, Mr. Grijalva, and Ms.
Jackson Lee) introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to require reporting by the
National Institutes of Health on requests for funding research that
were not granted and had the greatest potential for improving public
health, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Missed Opportunities in Public
Health and Biomedical Research Act of 2020''.
SEC. 2. FINDINGS.
Congress finds the following:
(1) Biomedical research sponsored by the National
Institutes of Health (refered to in this section as the
``NIH'') provides numerous treatments and discoveries that
improve and save lives, defend the Nation against bioterrorism
and emerging pandemics, strengthen the national economy, and
support the next generation of researchers in the United
States.
(2) While the NIH is the largest source of funding for
medical research in the world, the percentage of grants awarded
has fallen over the last 20 years.
(3) The NIH Center for Scientific Review works with over
25,000 expert reviewers and applies the highest level of
scientific and ethical standards to almost 50,000 competitive
grant applications every year.
(4) The NIH's peer review process is a time-tested and
proven method of identifying the most promising biomedical
research proposals.
SEC. 3. ANNUAL REPORTING BY NIH ON MISSED OPPORTUNITIES.
The Public Health Service Act (42 U.S.C. 201 et seq.) is amended by
inserting after section 403D of such Act (42 U.S.C. 283a-3) the
following:
``SEC. 403E. ANNUAL REPORTING ON MISSED OPPORTUNITIES.
``(a) In General.--Not later than the last day of the first fiscal
quarter following the end of each fiscal year, the Director of NIH
shall submit a report to Congress identifying, with respect to each
national research institute, each national center, and the Office of
the Director of NIH--
``(1) the success rate of research project grant
applications reviewed during such fiscal year;
``(2) the top two research project grant applications
reviewed during such fiscal year that were not funded; and
``(3) if the success rate described in paragraph (1) is
lower than 32 percent, the top research project grant
applications that were reviewed and could have been funded to
achieve a success rate of at least 32 percent.
``(b) Trade Secrets and Confidential Information; Researcher
Names.--This section does not authorize the Secretary to disclose--
``(1) any information that is a trade secret or
confidential information subject to section 552(b)(4) of title
5, United States Code, or section 1905 of title 18, United
States Code; or
``(2) the names of the researchers proposed to carry out
research pursuant to unfunded research project grant
applications described in subsection (a).
``(c) Definitions.--In this section:
``(1) The term `success rate' means the percentage of
research project grant applications reviewed during the
respective fiscal year that received funding.
``(2) The term `top' means having the greatest potential
for--
``(A) improving public health;
``(B) advancing biomedical and behavioral research;
and
``(C) increasing fundamental knowledge about the
nature and behavior of living systems, and the
application of that knowledge towards enhancing health,
lengthening life, and reducing illness and
disability.''.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line